TENAX THERAPEUTICS, INC.·4

Jan 2, 1:51 PM ET

Jebsen Michael B 4

4 · TENAX THERAPEUTICS, INC. · Filed Jan 2, 2018

Insider Transaction Report

Form 4
Period: 2017-12-29
Jebsen Michael B
Chief Financial Officer
Transactions
  • Disposition to Issuer

    common stock

    2017-12-29$0.43/sh+98$4268,264 total

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT